A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Yale researchers have created a new method for simulating “aging-like” chromosome errors in mouse eggs to better understand ...
First company to enable precision in vivo genome engineering, combining both cell-specific delivery and programmable, locus-specific gene insertion, with the potential to achieve physiological, durabl ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback